Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1978 1
1980 1
1981 2
1984 2
1985 1
1988 1
1992 1
1994 2
1995 1
1997 1
1999 1
2000 2
2001 3
2002 3
2003 2
2004 3
2005 1
2006 6
2007 4
2008 8
2009 10
2010 7
2011 14
2012 17
2013 10
2014 11
2015 11
2016 11
2017 13
2018 6
2019 8
2020 15
2021 24
2022 16
2023 14
2024 18
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Bardia A, Messersmith WA, Kio EA, Berlin JD, Vahdat L, Masters GA, Moroose R, Santin AD, Kalinsky K, Picozzi V, O'Shaughnessy J, Gray JE, Komiya T, Lang JM, Chang JC, Starodub A, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Wegener WA, Goswami T, Ocean AJ. Bardia A, et al. Among authors: goswami t. Ann Oncol. 2021 Jun;32(6):746-756. doi: 10.1016/j.annonc.2021.03.005. Epub 2021 Mar 16. Ann Oncol. 2021. PMID: 33741442 Free article. Clinical Trial.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group. Puzanov I, et al. J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z. J Immunother Cancer. 2017. PMID: 29162153 Free PMC article.
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
Tagawa ST, Balar AV, Petrylak DP, Kalebasty AR, Loriot Y, Fléchon A, Jain RK, Agarwal N, Bupathi M, Barthelemy P, Beuzeboc P, Palmbos P, Kyriakopoulos CE, Pouessel D, Sternberg CN, Hong Q, Goswami T, Itri LM, Grivas P. Tagawa ST, et al. Among authors: goswami t. J Clin Oncol. 2021 Aug 1;39(22):2474-2485. doi: 10.1200/JCO.20.03489. Epub 2021 Apr 30. J Clin Oncol. 2021. PMID: 33929895 Free PMC article. Clinical Trial.
A tissue-specific atlas of mouse protein phosphorylation and expression.
Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villén J, Haas W, Sowa ME, Gygi SP. Huttlin EL, et al. Among authors: goswami t. Cell. 2010 Dec 23;143(7):1174-89. doi: 10.1016/j.cell.2010.12.001. Cell. 2010. PMID: 21183079 Free PMC article.
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial.
Kalinsky K, Diamond JR, Vahdat LT, Tolaney SM, Juric D, O'Shaughnessy J, Moroose RL, Mayer IA, Abramson VG, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Goswami T, Wegener WA, Bardia A. Kalinsky K, et al. Among authors: goswami t. Ann Oncol. 2020 Dec;31(12):1709-1718. doi: 10.1016/j.annonc.2020.09.004. Epub 2020 Sep 15. Ann Oncol. 2020. PMID: 32946924 Free article. Clinical Trial.
Cell-Penetrating Protein/Corrole Nanoparticles.
Soll M, Goswami TK, Chen QC, Saltsman I, Teo RD, Shahgholi M, Lim P, Di Bilio AJ, Cohen S, Termini J, Gray HB, Gross Z. Soll M, et al. Among authors: goswami tk. Sci Rep. 2019 Feb 19;9(1):2294. doi: 10.1038/s41598-019-38592-w. Sci Rep. 2019. PMID: 30783138 Free PMC article.
Journal scan.
Goswami T, Bhattacharyya AK, Mason JD, Jones NS, Hughes RJ, Holland IM, Lale AM, Mason JD, Jones NS, Manning SC, Holman M. Goswami T, et al. Indian J Otolaryngol Head Neck Surg. 1999 Jan;51(1):98. doi: 10.1007/BF02996862. Indian J Otolaryngol Head Neck Surg. 1999. PMID: 23119501 Free PMC article. No abstract available.
Sublingual drug delivery.
Goswami T, Jasti B, Li X. Goswami T, et al. Crit Rev Ther Drug Carrier Syst. 2008;25(5):449-84. doi: 10.1615/critrevtherdrugcarriersyst.v25.i5.20. Crit Rev Ther Drug Carrier Syst. 2008. PMID: 19062634 Review.
Transporters as channels.
DeFelice LJ, Goswami T. DeFelice LJ, et al. Among authors: goswami t. Annu Rev Physiol. 2007;69:87-112. doi: 10.1146/annurev.physiol.69.031905.164816. Annu Rev Physiol. 2007. PMID: 17059369 Review.
239 results